Evidence map›Paper›PMID 36860612›Full record

ArticleMissouri medicine

Part II: Missouri's Fentanyl Poisonings Rise to Record Levels.

William V Stoecker, Colin L Smith, Elizabeth Connors

Open access · greenAbstract read
In one paragraph

Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

William V StoeckerS&A Technologies and The Dermatology Center, Rolla, Missouri and in the Department of Dermatology, University of Missouri Health Sciences Center, Columbia, Missouri.
Colin L SmithKirksville College of Osteopathic Medicine, A.T. Still University, Kirksville, Missouri.
Elizabeth ConnorsMissouri Institute of Mental Health, University of Missouri-St. Louis, St. Louis Missouri.
A.T. Still University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Missouri's dramatic rise in fentanyl-related overdoses was reported in Part I of this two-part series. In Part II, we report that previous efforts to combat the surge in illicit fentanyl supply from China failed, as Chinese factories shifted production to basic fentanyl precursor chemicals, known as dual-use pre-precursors. Mexican drug cartels now synthesize fentanyl from these basic chemicals and have overpowered the Mexican government. All efforts to reduce the fentanyl supply appear to be failing. Missouri has implemented harm reduction methods: training first responders and educating people who use drugs in safer practices. Harm reduction agencies are distributing naloxone at unprecedented levels. The "One Pill Can Kill" campaign begun by the Drug Enforcement Agency (DEA) in 2021 and foundations created by bereaved parents aim to educate young people on the extraordinary danger of counterfeit pills. In 2022, Missouri is at a crossroads, with record numbers of fatalities from illicit fentanyl and new levels of effort by harm reduction agencies to combat the soaring rate of deaths from this powerful narcotic.

Indexed as

Emergency RespondersAdolescentChinaFentanylGovernmentHumansMissouriFentanyl

Identifiers

PMID36860612
PMCPMC9970332
OpenAlexW4322758205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.